Clinical Trial of TQB3702 Tablets in Subjects With Systemic Lupus Erythematosus (SLE)

Clinical trial NCT06859931 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06859931
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2025-03-01
Primary completion: 2026-12-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.